Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Coronary Artery DiseaseAcute Coronary Syndrome
Interventions
DRUG

Prasugrel

Prasugrel 10mg/day

DRUG

Ticagrelor

Ticagrelor 90mg twice a day

Trial Locations (1)

26500

Cardiology Department Patras University Hospital, Pátrai

All Listed Sponsors
lead

University of Patras

OTHER

NCT01642940 - Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study | Biotech Hunter | Biotech Hunter